Articles from Iron Path Capital

PRO-SET Formulated Resin Systems, LLC, an Iron Path Capital holding company, today announced the acquisition of European-based Wessex Resins and Adhesives Ltd. (Wessex), a prominent player in the formulation and manufacturing of high-performance epoxy resins and adhesives. This marks the second acquisition for PRO-SET Formulated Resin Systems, following its acquisition of Gougeon Brothers, Inc. in May 2025.

Iron Path Capital, a private equity firm focused on healthcare and specialty industrials, today announced a growth partnership with Gougeon Brothers, Inc., a leading epoxy manufacturer in the composites and marine end markets.

Iron Path Capital (Iron Path), a private equity firm focused on healthcare and specialty industrials, today announced the appointment of Ian Thomas as Managing Director – Head of Business Development to lead origination and business development for the firm and its portfolio companies. His experience in both private equity and investment banking provides a wide expertise to drive Iron Path’s strategic growth and value-add capabilities.

Iron Path Capital (Iron Path), a private equity firm focused on healthcare and specialty industrials, today announced the appointment of industry veteran Jake Fitzgerald as Chief Executive Officer of PureTech Scientific LLC (PureTech), a global leader in glycolic acid synthesis and technology. PureTech was founded by Iron Path after acquiring the Glycolic Acid business from The Chemours Company last August.

Iron Path Capital (“Iron Path” or “IPC”), an operationally focused private equity firm investing in the specialty industrials and healthcare sectors, today announced the final closing of Iron Path Capital Fund I (“Fund I”), exceeding the $250 million target with total commitments of $273 million. The Fund I limited partners consist of a diverse group of global investors including leading endowments, fund of funds, institutional investors and family offices.

Iron Path Capital, a private equity firm focused on building differentiated businesses in the healthcare and specialty industrials sectors, is pleased to announce that Capitol Pain Institute (CPI) has acquired the ambulatory surgical center (ASC) Pain Care Surgery of Louisville. This strategic move allows CPI to offer more advanced procedures, including spinal cord and peripheral nerve stimulation, interspinous stabilization and fixation, and posterior SI joint fusion. The acquisition is the latest in CPI’s efforts to provide patients in Kentucky with comprehensive, personalized, and state-of-the-art care.

Iron Path Capital, a private equity firm focused on healthcare and specialty industrials, today announced a new strategic partnership with TruTech Servo Motors & Systems (TruTech), a technology leader in the design, engineering, and manufacturing of custom electric motors for use in high-performance applications. TruTech will serve as the first investment in Iron Path’s broader build-up strategy in industrial automation and motion control.

Iron Path Capital (“Iron Path”), a private equity firm focused on healthcare and specialty industrials, is pleased to announce its partnership with Aldon Corporation (“Aldon”), a leading private-label manufacturer and distributor to the healthcare, life science and STEM education end markets. Aldon will serve as the first investment under VION Biosciences LLC (“VION Biosciences”), Iron Path Capital’s go-forward roll-up platform in the life science sector that will be led by life science industry veteran and former Avantor executive, Mark Thornton.

PureTech Scientific LLC today announced the completion of its acquisition of the Glycolic Acid business from The Chemours Company (NYSE: CC) for $137 million in cash, making PureTech Scientific a global leader in the organic synthesis of ultra-high purity alpha hydroxy acids for the Life Sciences and Specialty Chemical industries. PureTech Scientific was founded and backed by Iron Path Capital, a private equity firm specializing in lower-middle market investments across the specialty industrial and healthcare sectors.

Iron Path Capital, a private equity firm focused on building differentiated businesses in the healthcare and specialty industrials sectors, is pleased to announce that Capitol Pain Institute (CPI) has acquired Balcones Pain Consultants and Water Leaf Surgery Center. This partnership adds three clinics and one ambulatory surgical center (ASC) in the Austin metropolitan area to CPI’s national interventional pain management platform. CPI currently operates in six states: Colorado, Indiana, Kentucky, Minnesota, Ohio, and Texas.

Iron Path Capital, a private equity firm focused on building differentiated businesses in the healthcare and specialty industrials sectors, is pleased to announce that Capitol Pain Institute (CPI) is entering the Minneapolis-St. Paul metropolitan market via the acquisition of Nura Pain Clinics (Nura). This partnership expands CPI’s network of clinics and ambulatory surgical centers (ASCs) in the Midwest, strengthening the ability to provide exceptional care to patients with chronic pain in the region. CPI’s expansion to Minnesota marks the company’s sixth state in its national platform. CPI currently operates in Colorado, Indiana, Kentucky, Ohio, and Texas.

Iron Path Capital, a private equity firm focused on building differentiated businesses in the healthcare and specialty industrials sectors, is pleased to announce that Capitol Pain Institute (CPI) is expanding its footprint to Colorado through four new acquisitions: Springs Rehabilitation, Spinal Diagnostics and Regenerative Medicine, The Peak Physical Medicine, and The Ascent Surgery Center. These partnerships mark CPI’s first entry into the state of Colorado and allow the partner physicians to both consolidate into one location serving Colorado Springs and expand into the growing Denver corridor. CPI currently has clinics and ambulatory surgical centers (ASCs) across Texas, Ohio, Kentucky, and Indiana. The Colorado entry marks CPI’s expansion into the fifth state in their national platform.

Iron Path Capital, a private equity firm focused on building differentiated businesses in the healthcare and specialty industrials sectors, is pleased to announce that Capitol Pain Institute (CPI) is expanding its quality patient care model through the acquisition of Wellspring Pain Solutions (Wellspring). This partnership is a step forward in CPI’s mission to create a leading national interventional pain management platform. In combination with CPI’s existing clinics and ambulatory surgical centers (ASCs) across Texas, Ohio and Kentucky, the acquisition of Wellspring in Indiana marks a strategic entry into a new state with a highly complementary clinic and ASC footprint.

Iron Path Capital, a private equity firm focused on healthcare and specialty industrials, today announced the addition of Ted Clark as a partner to lead investment initiatives with a focus on high-quality businesses in the specialty industrials sector. Clark joins Iron Path after stepping down as EVP and chief operating officer and transitioning to an advisory role with H.B. Fuller Company (NYSE: FUL), a global specialty chemical company founded in 1887. Clark joined H.B. Fuller following its 2017 acquisition of Royal Adhesives and Sealants (a platform Clark founded with Quad-C Management in 2003), where he served as president and CEO.

Iron Path Capital, a private equity firm focused on healthcare and specialty industrials, today announced its partnership with an affiliate of Capitol Pain Institute (CPI), an interventional pain management provider, to create a physician-led consolidation platform focused on delivering the highest quality care for patients with chronic pain.